Continuous manufacturing of pharmaceutical products: A density-insensitive near infrared method for the in-line monitoring of continuous powder streams

被引:6
作者
Velez-Silva, Natasha L. [1 ,2 ]
Drennen III, James K.
Anderson, Carl A. [1 ,2 ,3 ]
机构
[1] Duquesne Univ, Grad Sch Pharmaceut Sci, Pittsburgh, PA 15282 USA
[2] Duquesne Univ, Duquesne Ctr Pharmaceut Technol, Pittsburgh, PA 15282 USA
[3] 600 Forbes Ave, Pittsburgh, PA 15282 USA
关键词
Near infrared spectroscopy; Process analytical technology; Powder stream density; Model robustness; Continuous manufacturing process; SPECTROSCOPY; CALIBRATION; ROBUSTNESS; SCATTERING; MODELS; FLOW;
D O I
10.1016/j.ijpharm.2023.123699
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Near infrared (NIR) spectroscopy is a valuable analytical technique for monitoring chemical composition of powder blends in continuous pharmaceutical processes. However, the variation in density captured by NIR during spectral collection of dynamic powder streams at different flow rates often reduces the performance and robustness of NIR models. To overcome this challenge, quantitative NIR measurements are commonly collected across all potential manufacturing conditions, including multiple flow rates to account for the physical variations. The utility of this approach is limited by the considerable quantity of resources required to run and analyze an extensive calibration design at variable flow rates in a continuous manufacturing (CM) process. It is hypothesized that the primary variation introduced to NIR spectra from changing flow rates is a change in the density of the powder from which NIR spectra are collected. In this work, powder stream density was used as an efficient surrogate for flow rate in developing a quantitative NIR method with enhanced robustness against process rate variation. A density design space of two process parameters was generated to determine the conditions required to encompass the apparent density and spectral variance from increases in process rate. This apparent density variance was included in calibration at a constant low flow rate to enable the development of a density-insensitive NIR quantitative model with limited consumption of materials. The density-insensitive NIR model demonstrated comparable prediction performance and flow rate robustness to a traditional NIR model including flow rate variation ("gold standard" model) when applied to monitoring drug content in continuous runs at varying flow rates. The proposed platform for the development of in-line density-insensitive NIR methods is expected to facilitate robust analytical model performance across variable continuous manufacturing production scales while improving the material efficiency over traditional robust modeling approaches for calibration development.
引用
收藏
页数:13
相关论文
共 36 条
[1]  
Anderson C.A., 2018, Particles and Nanoparticles in Pharmaceutical Products: Design, Manufacturing, Behavior and Performance, P233
[2]   STANDARD NORMAL VARIATE TRANSFORMATION AND DE-TRENDING OF NEAR-INFRARED DIFFUSE REFLECTANCE SPECTRA [J].
BARNES, RJ ;
DHANOA, MS ;
LISTER, SJ .
APPLIED SPECTROSCOPY, 1989, 43 (05) :772-777
[3]   Extracting chemical information from spectral data with multiplicative light scattering effects by optical path-length estimation and correction [J].
Chen, Zeng-Ping ;
Morris, Julian ;
Martin, Elaine .
ANALYTICAL CHEMISTRY, 2006, 78 (22) :7674-7681
[4]  
Cogdill RP., 2006, Spectroscopy of Pharmaceutical Solids, V1, P313
[5]   Continuous manufacturing: the future in pharmaceutical solid dosage form manufacturing [J].
Desai, Parind Mahendrakumar ;
Van Vaerenbergh, Griet ;
Holman, Jim ;
Liew, Celine Valeria ;
Heng, Paul Wan Sia .
PHARMACEUTICAL BIOPROCESSING, 2015, 3 (05) :357-360
[6]   Integrated Continuous Pharmaceutical Technologies-A Review [J].
Domokos, Andras ;
Nagy, Brigitta ;
Szilagyi, Botond ;
Marosi, Gyorgy ;
Nagy, Zsombor Kristof .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2021, 25 (04) :721-739
[7]  
FDA U. S., 2023, Q13 Continuous Manufacturing of Drug Dubstances and Drug Products
[8]   An audit of pharmaceutical continuous manufacturing regulatory submissions and outcomes in the US [J].
Fisher, Adam C. ;
Liu, William ;
Schick, Andreas ;
Ramanadham, Mahesh ;
Chatterjee, Sharmista ;
Brykman, Raphael ;
Lee, Sau L. ;
Kozlowski, Steven ;
Boam, Ashley B. ;
Tsinontides, Stelios C. ;
Kopcha, Michael .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 622
[9]   Process Analytical Technology for continuous manufacturing of solid-dosage forms [J].
Fonteyne, Margot ;
Vercruysse, Jurgen ;
De Leersnyder, Fien ;
Van Snick, Bernd ;
Vervaet, Chris ;
Remon, Jean Paul ;
De Beer, Thomas .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2015, 67 :159-166
[10]   Supervised Extended Iterative Optimization Technology for Estimation of Powder Compositions in Pharmaceutical Applications: Method and Lifecycle Management [J].
Garcia Munoz, Salvador ;
Hernandez Torres, Eduardo .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2020, 59 (21) :10072-10081